Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Among authors: schlottmann pg. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.
Brown DM, Nguyen QD, Marcus DM, Boyer DS, Patel S, Feiner L, Schlottmann PG, Rundle AC, Zhang J, Rubio RG, Adamis AP, Ehrlich JS, Hopkins JJ; RIDE and RISE Research Group. Brown DM, et al. Among authors: schlottmann pg. Ophthalmology. 2013 Oct;120(10):2013-22. doi: 10.1016/j.ophtha.2013.02.034. Epub 2013 May 22. Ophthalmology. 2013. PMID: 23706949 Free article. Clinical Trial.
New Treatment Modalities for Neovascular Age-Related Macular Degeneration.
Schlottmann PG, Alezzandrini AA, Zas M, Rodriguez FJ, Luna JD, Wu L. Schlottmann PG, et al. Asia Pac J Ophthalmol (Phila). 2017 Nov-Dec;6(6):514-519. doi: 10.22608/APO.2017258. Epub 2017 Sep 14. Asia Pac J Ophthalmol (Phila). 2017. PMID: 28933517 Free article. Review.
Latest Developments in the Management of AMD.
Chang A, Schlottmann PG, Chan RVP. Chang A, et al. Among authors: schlottmann pg. Asia Pac J Ophthalmol (Phila). 2017 Nov-Dec;6(6):477-478. doi: 10.22608/APO.2017480. Asia Pac J Ophthalmol (Phila). 2017. PMID: 29204992 Free article. No abstract available.
THE ANGIOPOIETIN/TIE PATHWAY IN RETINAL VASCULAR DISEASES: A Review.
Heier JS, Singh RP, Wykoff CC, Csaky KG, Lai TYY, Loewenstein A, Schlottmann PG, Paris LP, Westenskow PD, Quezada-Ruiz C. Heier JS, et al. Among authors: schlottmann pg. Retina. 2021 Jan 1;41(1):1-19. doi: 10.1097/IAE.0000000000003003. Retina. 2021. PMID: 33136975 Review.
Reply.
Heier JS, Singh RP, Wykoff CC, Csaky KG, Lai TYY, Loewenstein A, Schlottmann PG, Paris LP, Westenskow PD, Quezada-Ruiz C. Heier JS, et al. Among authors: schlottmann pg. Retina. 2021 Sep 1;41(9):e56-e58. doi: 10.1097/IAE.0000000000003183. Retina. 2021. PMID: 34432748 No abstract available.
49 results